Venture capital-backed biopharmaceutical startup Kite Pharma has filed for an IPO.
Jefferies, Credit Suisse Securities and Cowen and Company are acting as lead underwriters, while Stifel is acting as co-manager.
The company, which is backed by Alta Partners and TPG Capital, said that the number of shares to be offered and the price range have yet to be determined.
Kite is focused on developing engineered autologous T cell therapy products for the treatment of cancer.
In May last year Kite raised $20m in Series A capital from existing backers and new investor Alta.
Earlier this month it was reported that TPG was planning to float its portfolio company American Tire Distributors.
Copyright © 2014 AltAssets